Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00555425 · ClinicalTrials.gov registry record · Phase 4
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 113
- Enrollment target
NCT00555425 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 113 participants.
The verdict
NCT00555425, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 113 participants
- Enrollment target
Study Summary
The aim of the study is to determine whether buprenorphine/naloxone maintenance versus detoxification using buprenorphine/naloxone, in prescription opioid dependent patients receiving primary care management and drug counseling in an office-based setting, leads to decreased illicit opioid use.
Interventions
- BEHAVIORAL Behavioral: Buprenorphine/naloxone maintenance (Mtn)
- BEHAVIORAL Behavioral: Buprenorphine/naloxone detoxification (Dtx)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2008-07 |
| Est. Completion | 2013-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00555425
The ClinicalTrials.gov registry entry for NCT00555425 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Behavioral: Buprenorphine/naloxone maintenance (Mtn) is the first listed.
NCT00555425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00555425 about?
NCT00555425 is a clinical study titled "Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence". The aim of the study is to determine whether buprenorphine/naloxone maintenance versus detoxification using buprenorphine/naloxone, in prescription opioid dependent patients receiving primary care management and drug counseling in an office-based setting, leads to decreased illicit opioid use.
What is the current status of trial NCT00555425?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 113 participants. The study started on 2008-07. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00555425?
The interventions under investigation include: Behavioral: Buprenorphine/naloxone maintenance (Mtn) (BEHAVIORAL), Behavioral: Buprenorphine/naloxone detoxification (Dtx) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00555425?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.